INNV · InnovAge Holding Corp.
$11.52
-0.30 (-2.50%)
At close · Jul 29
Market Cap
$1.60B
Shares
135.74M
InnovAge Holding Corp. Earnings Call Transcripts
Every quarterly earnings call for InnovAge Holding Corp. (INNV) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲0.7%
$172.86M
−$12.71M
'22 Q4
22-09-13
▼1.1%
$171.22M
−$13.07M
'23 Q1
22-11-08
▼4.5%
$167.46M
−$9.79M
'23 Q2
23-02-07
▼2.7%
$172.54M
−$6.63M
'23 Q3
23-05-09
▲2.3%
$176.87M
−$11.18M
'23 Q4
23-09-12
▲6.6%
$182.49M
−$10.30M
'24 Q1
23-11-07
▲12.8%
$188.90M
−$3.45M
'24 Q2
24-02-06
▲11.9%
$193.07M
−$5.89M
'24 Q3
24-05-07
▲12.7%
$199.40M
−$1.70M
'24 Q4
24-09-10
▲12.4%
$205.14M
−$4.93M
'25 Q1
24-11-05
▲10.6%
$209.00M
−$13.22M
'25 Q2
25-02-04
▲13%
$218.14M
−$11.38M
'25 Q3
25-05-06
▲11%
$221.42M
−$785,000
'25 Q4
25-09-09
▲15.1%
$236.10M
$8.02M
'26 Q1
25-11-04
▲14.7%
$239.71M
$10.62M
'26 Q2
26-02-03
LATEST
▲15.5%
$251.94M
−$29.46M
'26 Q3
26-05-05
Earnings call
FY26 · Q3
2026-05-05
InnovAge Holding Corp. Q3 FY2026 Earnings Call
Revenue
$251.94M
▲ 15.5% YoY Diluted EPS
$-0.22
Gross margin
24.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q2
2026-02-03
InnovAge Holding Corp. Q2 FY2026 Earnings Call
Revenue
$239.71M
▲ 14.7% YoY Diluted EPS
$0.08
Gross margin
22.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2025-11-04
InnovAge Holding Corp. Q1 FY2026 Earnings Call
Confident tone
Financial performance and growth
PACE model resilience vs. broader value-based care
Pharmacy in-sourcing and cost structure
Revenue
$236.10M
▲ 15.1% YoY Diluted EPS
$0.06
Gross margin
21.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2025-09-09
InnovAge Holding Corp. Q4 FY2025 Earnings Call
Revenue
$221.42M*
▲ 11% YoY Gross margin
18.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-05-06
InnovAge Holding Corp. Q3 FY2025 Earnings Call
Positive tone
Census Growth and Participant Base
Financial Performance and Reaffirmed Guidance
PACE Advocacy and Policy Engagement
Revenue
$218.14M
▲ 13% YoY Diluted EPS
$-0.08
Gross margin
18.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-02-04
InnovAge Holding Corp. Q2 FY2025 Earnings Call
Positive tone
Clinical and Operational Value Initiatives
Pharmacy Insourcing Strategy
De Novo and Acquired Centers
Revenue
$209.00M
▲ 10.6% YoY Diluted EPS
$-0.10
Gross margin
17.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2024-11-05
InnovAge Holding Corp. Q1 FY2025 Earnings Call
Revenue
$205.14M
▲ 12.4% YoY Diluted EPS
$-0.04
Gross margin
16.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2024-09-10
InnovAge Holding Corp. Q4 FY2024 Earnings Call
Positive tone
Fiscal 2024 financial results
De novo center ramp
Fiscal 2025 guidance
Revenue
$199.40M*
▲ 12.7% YoY Gross margin
18.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-05-07
InnovAge Holding Corp. Q3 FY2024 Earnings Call
Positive tone
PACE demand and enrollment growth
De novo center expansion
Financial guidance and outlook
Revenue
$193.07M
▲ 11.9% YoY Diluted EPS
$-0.04
Gross margin
17.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-02-06
InnovAge Holding Corp. Q2 FY2024 Earnings Call
Revenue
$188.90M
▲ 12.8% YoY Diluted EPS
$-0.03
Gross margin
17.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2023-11-07
InnovAge Holding Corp. Q1 FY2024 Earnings Call
Revenue
$182.49M
▲ 6.6% YoY Diluted EPS
$-0.08
Gross margin
15.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2023-09-12
InnovAge Holding Corp. Q4 FY2023 Earnings Call
Revenue
$176.87M*
▲ 2.3% YoY Gross margin
16.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-05-09
InnovAge Holding Corp. Q3 FY2023 Earnings Call
Revenue
$172.54M
▼ 2.7% YoY Diluted EPS
$-0.05
Gross margin
16.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-02-07
InnovAge Holding Corp. Q2 FY2023 Earnings Call
Revenue
$167.46M
▼ 4.5% YoY Diluted EPS
$-0.07
▼ 800% YoY Gross margin
13.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2022-11-08
InnovAge Holding Corp. Q1 FY2023 Earnings Call
Revenue
$171.22M
▼ 1.1% YoY Diluted EPS
$-0.10
▼ 266.7% YoY Gross margin
12.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2022-09-13
InnovAge Holding Corp. Q4 FY2022 Earnings Call
Revenue
$172.86M*
▲ 0.7% YoY
Rev · 7q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-05-10
InnovAge Holding Corp. Q3 FY2022 Earnings Call
Revenue
$177.36M
▲ 13.5% YoY Diluted EPS
$-0.02
Gross margin
15.8%
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-02-09
InnovAge Holding Corp. Q2 FY2022 Earnings Call
Revenue
$175.35M
▲ 11.5% YoY Diluted EPS
$0.01
▼ 87.5% YoY
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2021-11-09
InnovAge Holding Corp. Q1 FY2022 Earnings Call
Revenue
$173.07M
▲ 13.4% YoY Diluted EPS
$0.06
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2021-09-21
InnovAge Holding Corp. Q4 FY2021 Earnings Call
Revenue
$171.62M*
Rev · 4q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-05-10
InnovAge Holding Corp. Q3 FY2021 Earnings Call
Revenue
$156.31M
▲ 8% YoY Diluted EPS
$-0.09
▼ 250% YoY
Rev · 4q
Audio
Transcript
Slides
8-K10-Q
Showing 1–21 of 21 earnings calls
Key facts
CIK
1834376
CUSIP
45784A104
13F (30d)
14 filings
14 filers
Visit website
Investor relations